EICHORPublic-registry site landscape for NCT06462820, “SAINT for MDD in an Inpatient Setting Follow-on”, a Major Depressive Disorder study sponsored by Magnus Medical. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06462820 (registry record) |
| Study title | SAINT for MDD in an Inpatient Setting Follow-on |
| Official title | SAINT® Neuromodulation System for the Treatment of Depression in an Inpatient Setting |
| Sponsor | Magnus Medical |
| Condition(s) | Major Depressive Disorder; Major Depressive Episode; Suicidal Ideation |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 4 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06462820.
Eichor generates a preliminary site-risk snapshot for NCT06462820 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Major Depressive Disorder trials
← Eichor home · All tracked trials · Major Depressive Disorder studies · Weekly briefs
